Man Chen
Shandong Provincial Hospital · 930 works · 19,590 citations · h-index 64
Top works
- Proof of principle for epitope-focused vaccine design
- Prefusion F–specific antibodies determine the magnitude of RSV neutralizing activity in human sera
- Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions
- Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors
- Study on the adsorption of Cu(II) by EDTA functionalized Fe3O4 magnetic nano-particles
- Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic Hypermutation
- High efficient removal of Pb (II) by amino-functionalized Fe3O4 magnetic nano-particles
- Metal Exchange Method Using Au 25 Nanoclusters as Templates for Alloy Nanoclusters with Atomic Precision
- Dual Functions of Microglia in Ischemic Stroke
- Design and numerical investigation of A HVDC vacuum switch based on artificial current zero
- Fatty acids production from hydrogen and carbon dioxide by mixed culture in the membrane biofilm reactor
- The Efficiency of Heptafluoropropane Fire Extinguishing Agent on Suppressing the Lithium Titanate Battery Fire
- D-dimer level is associated with the severity of COVID-19
- Temperature dependent selective gas sorption of the microporous metal-imidazolate framework [Cu(L)] [H 2 L = 1,4-di(1H-imidazol-4-yl)benzene]
- Enhancing sludge methanogenesis with improved redox activity of extracellular polymeric substances by hematite in red mud
- Characterization of a Prefusion-Specific Antibody That Recognizes a Quaternary, Cleavage-Dependent Epitope on the RSV Fusion Glycoprotein
- Experimental study on thermal runaway and fire behaviors of large format lithium iron phosphate battery
- Correction: Corrigendum: Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state
- Clinical Characteristics and Outcomes of COVID-19 Patients With a History of Stroke in Wuhan, China
- Iterative structure-based improvement of a fusion-glycoprotein vaccine against RSV